---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-23-000067"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T05:05:34.168127+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q1 revenue up 11.7% to $666.2M, net loss $24.9M, raises 2023 EBITDA guidance >$430M

## Summary
- Revenue $666.2M (+11.7% YoY); same-facility revenue +10.3% (cases +5.3%, revenue per case +4.8%).
- Net loss attributable to SGRY $24.9M vs net income $12.2M in Q1 2022; Adjusted EBITDA $90.1M (+17% from $77.1M).
- Raises 2023 Adjusted EBITDA guidance to >$430M; Q1 free cash flow $20.5M, deployed $60M on five acquisitions.
- New strategic partnerships with Intermountain Health and OhioHealth for expansion in new markets.
- Net debt to EBITDA 4.3x; liquidity ~$800M ($245.5M cash + $545.9M revolver availability).

## SEC filing metadata
- accession: 0001638833-23-000067
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000067/0001638833-23-000067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000067/sgry-20230501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-23-000067
- JSON: https://secwatch.observer/filing/0001638833-23-000067.json
- Plain text: https://secwatch.observer/filing/0001638833-23-000067.txt

## Key facts
- Earnings Releases
  Surgery Partners, Inc. updated its full year 2023 guidance (raised).
  - Period: full year 2023
  - Guidance: raised
  - Result: guidance update
  source text: The Company raises projected 2023 Adjusted EBITDA to be greater than $430 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000067/0001638833-23-000067-index.htm
- Earnings Releases
  Surgery Partners, Inc. reported first quarter ended March 31, 2023 results: revenue $666.2 million, net income $(24.9) million. Guidance raised.
  - Period: first quarter ended March 31, 2023
  - Revenue: $666.2 million
  - Net income: $(24.9) million
  - Guidance: raised
  - Result: reported results
  source text: a leading provider of surgical services, today announced financial results for the first quarter ended March 31, 2023. • Revenue increased 11.7% from the prior year period to $666.2 million ◦ Same-facility revenue increasing 10.3% • Net loss attributable to Surgery Partners, Inc. was $24.9 million ◦ Adjusted EBITDA of $90.1 million; 17% greater than the prior year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883323000067/0001638833-23-000067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.